The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Cyclin E and Survival in Patients with Breast Cancer
Open accessAbstract
BACKGROUND: Cyclin E, a regulator of the cell cycle, affects the behavior of breast-cancer cells. We investigated whether levels of cyclin E in the tumor correlated with survival among patients with breast cancer. METHODS: Tumor tissue from 395 patients with breast cancer was assayed for cyclin E, cyclin D1, cyclin D3, and the HER-2/neu oncogene with the use of Western blot analysis. Full-length, low-molecular-weight, and total cyclin E were measured. Immunohistochemical assessments of cyclin E were also made of 256 tumors. We sought correlations between levels of these molecular markers and disease-specific and overall survival. RESULTS: The median follow-up was 6.4 years. A high level of the low-molecular-weight isoforms of cyclin E, as detected by Western blotting, correlated strongly with disease-specific survival whether axillary lymph nodes were negative or positive for metastases (P<0.001). Among 114 patients with stage I breast cancer, none of the 102 patients with low levels of cyclin E in the tumor had died of breast cancer by five years after diagnosis, whereas all 12 patients with a high level of low-molecular-weight cyclin E had died of breast cancer within that period. In multivariate analysis, a high total cyclin E level or high levels of the low-molecular-weight forms of cyclin E were significantly correlated with poor outcome. The hazard ratio for death from breast cancer for patients with high total cyclin E levels as compared with those with low total cyclin E levels was 13.3--about eight times as high as the hazard ratios associated with other independent clinical and pathological risk factors. CONCLUSIONS: Levels of total cyclin E and low-molecular-weight cyclin E in tumor tissue, as measured by Western blot assay, correlate strongly with survival in patients with breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Polychemotherapy for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(98)03301-7 · Cited by 2,042
Human Cyclin E, a Nuclear Protein Essential for the G1-to-S Phase Transition
Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., & Pagano, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2612 · Cited by 1,148
Resnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669-1679.1994 · Cited by 965
Porter, P. L., Malone, K. E., Heagerty, P. J., Alexander, G. M., Gatti, L. A., Firpo, E. J., Daling, J. R., & Roberts, J. M. (1997) · Nature Medicine · doi:10.1038/nm0297-222 · Cited by 901
Isolation of three novel human cyclins by rescue of G1 cyclin (cln) function in yeast
Lew, D. J., Dulić, V., & Reed, S. I. (1991) · Cell · doi:10.1016/0092-8674(91)90042-w · Cited by 833
Deregulated cyclin E induces chromosome instability
Spruck, C. H., Won, K.-A., & Reed, S. I. (1999) · Nature · doi:10.1038/45836 · Cited by 692
Expression and amplification of cyclin genes in human breast cancer.
Buckley, M. F., Sweeney, K. J. E., Hamilton, J. A., Sini, R. L., Manning, D. L., Nicholson, R. I., DeFazio, A., Watts, C. K. W., Musgrove, E. A., & Sutherland, R. L. (1993) · PubMed · Cited by 667
Resnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669 · Cited by 664
Voogd, A. C., Nielsen, M., Peterse, J. L., Blichert-Toft, M., Bartelink, H., Overgaard, M., van Tienhoven, G., Andersen, K. W., Sylvester, R. J., van Dongen, J. A., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1688 · Cited by 562
Redundant cyclin overexpression and gene amplification in breast cancer cells.
Keyomarsi, K., & Pardee, A. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1112 · Cited by 512
Self-citationCyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
Lees, E., Faha, B., Dulic, V, Reed, S. I., & Harlow, E. (1992) · Genes & Development · doi:10.1101/gad.6.10.1874 · Cited by 438
THE NATURAL DURATION OF CANCER
Lazarus-Barlow, W. S., & Leeming, J. H. (1924) · BMJ · doi:10.1136/bmj.2.3320.266 · Cited by 427
Cyclin E, a Potential Prognostic Marker in Breast Cancer.
Keyomarsi, K. (1997) · doi:10.21236/ada341275 · Cited by 344
Self-citationInduction of Mammary Gland Hyperplasia and Carcinomas in Transgenic Mice Expressing Human Cyclin E
Bortner, D. M., & Rosenberg, M. P. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.1.453 · Cited by 245
Deregulation of cyclin E in breast cancer.
Keyomarsi, K., Conte, D., Toyofuku, W. M., & Fox, M. (1995) · PubMed · Cited by 222
Self-citationTumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight Forms
Porter, D. C., Zhang, N., Danes, C., McGahren, M. J., Harwell, R. M., Faruki, S., & Keyomarsi, K. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6254-6269.2001 · Cited by 194
Self-citationThe Evaluation of Estrogen Receptor in Primary Breast Carcinoma by Computer-Assisted Image Analysis
Bacus, S., Flowers, J. L., Press, M. F., Bacus, J. W., & Mccarty, K. S. (1988) · American Journal of Clinical Pathology · doi:10.1093/ajcp/90.3.233 · Cited by 193
Self-citationNielsen, N., Arnerlöv, C., Emdin, S. O., & Landberg, G. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.451 · Cited by 192
The role of cyclin E in cell proliferation, development and cancer
Keyomarsi, K., & Herliczek, T. W. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_14 · Cited by 151
Self-citationCyclin E, a redundant cyclin in breast cancer
Gray-Bablin, J., Zalvide, J. B., Fox, M., Knickerbocker, C. J., DeCaprio, J. A., & Keyomarsi, K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15215 · Cited by 129
Self-citationCyclin E and cyclin A as candidates for the restriction point protein.
Dou, Q. P., Levin, A., Zhao, S., et al. (1993) · PubMed · Cited by 121
Processing of cyclin E differs between normal and tumor breast cells.
Harwell, R. M., Porter, D. C., Danes, C. G., & Keyomarsi, K. (2000) · PubMed · Cited by 100
Self-citationDifferent expression patterns of cyclins A, D1 and E in human colorectal cancer
Wang, A., Yoshimi, N., Suzui, M., Yamauchi, A., Tarao, M., & Mori, H. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01226270 · Cited by 79
Donnellan, R. B., Kleinschmidt, I., & Chetty, R. (2001) · Human Pathology · doi:10.1053/hupa.2001.21141 · Cited by 67
Cyclin E overexpression in relapsed adult acute lymphoblastic leukemias of B-cell lineage
Scuderi, R., Palucka, K. A., Pokrovskaja, K., Björkholm, M., Wiman, K. G., & Pisa, P. (1996) · Blood · doi:10.1182/blood.v87.8.3360.bloodjournal8783360 · Cited by 56
Cited by
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Cyclin-Dependent Kinase Pathways As Targets for Cancer Treatment
Shapiro, G. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7689 · Cited by 1,036
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904
Self-citationGoldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thürlimann, B., & Senn, H.-J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.576 · Cited by 697
Metadata
- Authors
- Keyomarsi, K., Tucker, S. L., Buchholz, T. A., Callister, M., Ding, Y., Hortobagyi, G. N., Bedrosian, I., Knickerbocker, C., Toyofuku, W., Lowe, M., Herliczek, T. W., & Bacus, S. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-11-14
- Volume
- 347
- Issue
- 20
- Pages
- 1566-1575
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1995788690
- Cited by
- 557
- References
- 31
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.